Editorial: At a time when anxieties about body image are rife, the idealisation of skinniness is too dangerous to leave to the whims of the fashion industry
After years of setbacks, dementia researchers are getting excited about a new antibody drug called lecanemab. No one expects it to stop cognitive decline, but even slowing it would be a breakthrough